35986841_10216840653711318_1105697261150535680_n
Normal view MARC view ISBD view

Preparing of Cyclodextrin Polymeric Nanoparticles for Enhancing Drug Bioavailability // GP // Dr. Eman Saddar // T.A. Heidi Ayman Mahmoud (2018 - 2019)

By: Assem Mohamed Habib 154375.
Contributor(s): Rozana Akmal Kamal 150271 | Mariam Magdy Aziz 153587 | Salma Ahmed Khalifa 150747.
Material type: TextTextSeries: PharmaciesDISTINGUISHED PROJECTS 2019. Publisher: GIZA : MSA, 2019Description: 62 P.Subject(s): Cyclodextrin Polymeric Nanoparticles -- Enhancing Drug -- BioavailabilityDDC classification: 547 Online resources: FULL TEXT PRESS HERE Summary: Rosuvastatin calcium is one of a statin medication, used to prevent cardiovascular disease in those at high risk and treat abnormal lipids. It is a poorly soluble drug with oral bioavailability 20% due to extensive first pass effect. The study aimed to formulate cyclo-dextrin loaded polyrotaxane nanoparticles loaded with Rosuvastatin Calcium to improve its solubility, efficacy and reduce side effects. The effects of polymers (PVP), cyclodextrin concentrations or their combinations at different polymers ratios on the drug solubility dissolution rate was studied. The Experimental studies: Polyrotaxane was prepared by dissolving drug, PVP and cyclodextrane all together. The mixture was cooled for 24 hour to allow precipitation of drug- polyrotaxane powder, then dried at at 40 oC for 24 hours. The dried powdered was weighted. The drug content of polyrotaxane was determined. 0.05 g of the prepared polyrotaxane was dissolved in 10 ml methanol, to guarantee complete drug solubility. The drug concentration was measured spectrophotometrically at wavelength 243nm. The dissolution test used to compare between the poorly soluble rosuvastatin drug and polyrotaxane. Differential scanning calorimetry test used to concern with the measurement of energy acquired or emitted by a sample of matter when it is heated or cooled. It also provides information about endothermic and exothermic processes. X- Ray powder diffraction is a technique that utilizes x- ray scattering pointed on crystals of powder to give identity and information about the crystalline structure. The Results: The powder weight was 2.8gm presents 22.85 % yield. Five mg of polyrotaxane contains 3.575 mg pure drug (71.5% drug loading and 1%.encapsulation efficiency. Polyrotaxane complex enhance both drug solubility and dissolution.
List(s) this item appears in: Pharmacy D. G. P 2018 / 2019
Tags from this library: No tags from this library for this title. Log in to add tags.
    Average rating: 0.0 (0 votes)
Item type Current location Call number Status Date due Barcode
Distinguished Graduation Projects Distinguished Graduation Projects Centeral Library
Soft Copy located on library Cataloge
GP37PH2019 - OCHEM (Browse shelf) Available 82221

Pharmacy - Organic Chemistry

Rosuvastatin calcium is one of a statin medication, used to prevent cardiovascular disease in those at
high risk and treat abnormal lipids. It is a poorly soluble drug with oral bioavailability 20% due to
extensive first pass effect. The study aimed to formulate cyclo-dextrin loaded polyrotaxane
nanoparticles loaded with Rosuvastatin Calcium to improve its solubility, efficacy and reduce side
effects. The effects of polymers (PVP), cyclodextrin concentrations or their combinations at different
polymers ratios on the drug solubility dissolution rate was studied.
The Experimental studies: Polyrotaxane was prepared by dissolving drug, PVP and
cyclodextrane all together. The mixture was cooled for 24 hour to allow precipitation of drug-
polyrotaxane powder, then dried at at 40 oC for 24 hours. The dried powdered was weighted. The drug
content of polyrotaxane was determined. 0.05 g of the prepared polyrotaxane was dissolved in 10 ml
methanol, to guarantee complete drug solubility. The drug concentration was measured
spectrophotometrically at wavelength 243nm. The dissolution test used to compare between the poorly
soluble rosuvastatin drug and polyrotaxane. Differential scanning calorimetry test used to concern with
the measurement of energy acquired or emitted by a sample of matter when it is heated or cooled. It
also provides information about endothermic and exothermic processes. X- Ray powder diffraction is a
technique that utilizes x- ray scattering pointed on crystals of powder to give identity and information
about the crystalline structure.
The Results: The powder weight was 2.8gm presents 22.85 % yield. Five mg of polyrotaxane
contains 3.575 mg pure drug (71.5% drug loading and 1%.encapsulation efficiency. Polyrotaxane
complex enhance both drug solubility and dissolution.

There are no comments for this item.

Log in to your account to post a comment.

Click on an image to view it in the image viewer